Order Article Reprints

Dhakal B, Li CMY, Li R, Yeo K, Wright JA, Gieniec KA, Vrbanac L, Sammour T, Lawrence M, Thomas M, et al. The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers. 2022; 14(4):1043. https://doi.org/10.3390/cancers14041043

Dhakal, Bimala, Celine Man Ying Li, Runhao Li, Kenny Yeo, Josephine A. Wright, Krystyna A. Gieniec, Laura Vrbanac, Tarik Sammour, Matthew Lawrence, Michelle Thomas, and et al. 2022. "The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing" Cancers 14, no. 4: 1043. https://doi.org/10.3390/cancers14041043

Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., Vrbanac, L., Sammour, T., Lawrence, M., Thomas, M., Lewis, M., Perry, J., Worthley, D. L., Woods, S. L., Drew, P., Sallustio, B. C., Smith, E., Horowitz, J. D., Maddern, G. J., ... Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 1043. https://doi.org/10.3390/cancers14041043